ANIX
Price
$3.44
Change
+$0.09 (+2.69%)
Updated
Jul 18 closing price
Capitalization
110.81M
54 days until earnings call
VERA
Price
$23.05
Change
-$0.71 (-2.99%)
Updated
Jul 18 closing price
Capitalization
1.47B
18 days until earnings call
Interact to see
Advertisement

ANIX vs VERA

Header iconANIX vs VERA Comparison
Open Charts ANIX vs VERABanner chart's image
Anixa Biosciences
Price$3.44
Change+$0.09 (+2.69%)
Volume$82.66K
Capitalization110.81M
Vera Therapeutics
Price$23.05
Change-$0.71 (-2.99%)
Volume$756.22K
Capitalization1.47B
ANIX vs VERA Comparison Chart in %
Loading...
ANIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANIX vs. VERA commentary
Jul 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANIX is a Hold and VERA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 21, 2025
Stock price -- (ANIX: $3.44 vs. VERA: $23.05)
Brand notoriety: ANIX and VERA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANIX: 52% vs. VERA: 41%
Market capitalization -- ANIX: $110.81M vs. VERA: $1.47B
ANIX [@Biotechnology] is valued at $110.81M. VERA’s [@Biotechnology] market capitalization is $1.47B. The market cap for tickers in the [@Biotechnology] industry ranges from $293.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANIX’s FA Score shows that 0 FA rating(s) are green whileVERA’s FA Score has 0 green FA rating(s).

  • ANIX’s FA Score: 0 green, 5 red.
  • VERA’s FA Score: 0 green, 5 red.
According to our system of comparison, VERA is a better buy in the long-term than ANIX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANIX’s TA Score shows that 3 TA indicator(s) are bullish while VERA’s TA Score has 4 bullish TA indicator(s).

  • ANIX’s TA Score: 3 bullish, 5 bearish.
  • VERA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, VERA is a better buy in the short-term than ANIX.

Price Growth

ANIX (@Biotechnology) experienced а +9.55% price change this week, while VERA (@Biotechnology) price change was -3.23% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.68%. For the same industry, the average monthly price growth was +13.07%, and the average quarterly price growth was +34.43%.

Reported Earning Dates

ANIX is expected to report earnings on Sep 12, 2025.

VERA is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+2.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VERA($1.47B) has a higher market cap than ANIX($111M). ANIX YTD gains are higher at: 48.276 vs. VERA (-45.495). ANIX has higher annual earnings (EBITDA): -13.11M vs. VERA (-167.77M). VERA has more cash in the bank: 590M vs. ANIX (15.6M). ANIX has less debt than VERA: ANIX (221K) vs VERA (54.5M). ANIX (0) and VERA (0) have equivalent revenues.
ANIXVERAANIX / VERA
Capitalization111M1.47B8%
EBITDA-13.11M-167.77M8%
Gain YTD48.276-45.495-106%
P/E RatioN/AN/A-
Revenue00-
Total Cash15.6M590M3%
Total Debt221K54.5M0%
FUNDAMENTALS RATINGS
ANIX: Fundamental Ratings
ANIX
OUTLOOK RATING
1..100
9
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
PROFIT vs RISK RATING
1..100
81
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANIXVERA
RSI
ODDS (%)
Bearish Trend 3 days ago
85%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
82%
Momentum
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
82%
MACD
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
89%
Advances
ODDS (%)
N/A
Bullish Trend 4 days ago
86%
Declines
ODDS (%)
Bearish Trend 13 days ago
84%
Bearish Trend 6 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ANIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SLCGX32.300.12
+0.37%
Saratoga Large Capitalization Growth I
FDERX23.44N/A
N/A
Federated Hermes Equity Income R
RETSX89.76-0.06
-0.07%
Russell Inv Tax-Managed US Large Cap S
SUHAX34.97-0.19
-0.54%
DWS Health and Wellness A
MNDJX29.24-0.17
-0.58%
MFS New Discovery R4

ANIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANIX has been loosely correlated with LGND. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if ANIX jumps, then LGND could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANIX
1D Price
Change %
ANIX100%
+2.69%
LGND - ANIX
34%
Loosely correlated
+1.11%
KYMR - ANIX
32%
Poorly correlated
-0.37%
FDMT - ANIX
32%
Poorly correlated
-3.21%
VERA - ANIX
31%
Poorly correlated
-2.99%
GLUE - ANIX
31%
Poorly correlated
+0.68%
More

VERA and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERA has been loosely correlated with KYMR. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if VERA jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERA
1D Price
Change %
VERA100%
-2.99%
KYMR - VERA
59%
Loosely correlated
-0.37%
LYRA - VERA
54%
Loosely correlated
-7.60%
OPORF - VERA
50%
Loosely correlated
N/A
BPMC - VERA
47%
Loosely correlated
N/A
BNTX - VERA
40%
Loosely correlated
-0.92%
More